Bod Australia Limited is a healthcare company that specializes in the development and distribution of cannabidiol and medical cannabis products. The company operates in various markets including Australia, the United Kingdom, the European Union, and the United States. It offers three main segments of products including Medical, Over The Counter (OTC) Cannabidiol/Hemp, and OTC Herbals. Bod Australia Limited collaborates with Drug Science UK to evaluate the efficiency of its MediCabilis medicinal cannabis in dealing with symptoms associated with SARS-CoV-2. The company was founded in 2014 and is located in Double Bay, Australia.